• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Key Features of Insulin Delivery Devices for Type 2 Diabetes: Type 2.0 Booth Survey.2型糖尿病胰岛素给药装置的关键特性:2.0型展位调查
Clin Diabetes. 2020 Jan;38(1):56-61. doi: 10.2337/cd19-0014.
2
Leveraging advances in diabetes technologies in primary care: a narrative review.利用初级保健中的糖尿病技术进步:叙述性评论。
Ann Med. 2021 Dec;53(1):805-816. doi: 10.1080/07853890.2021.1931427.
3
The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.持续皮下胰岛素泵联合持续血糖监测在门诊1型糖尿病青少年患者中的有效性:一项系统评价。
JBI Libr Syst Rev. 2012;10(42 Suppl):1-10. doi: 10.11124/jbisrir-2012-170.
4
5
Flexible insulin dosing improves health-related quality-of-life (HRQoL): a time trade-off survey.灵活胰岛素给药可改善健康相关生活质量(HRQoL):一项时间权衡调查。
J Med Econ. 2013 Nov;16(11):1357-65. doi: 10.3111/13696998.2013.846262. Epub 2013 Oct 11.
6
Implementation of Basal-Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen.基础-餐时胰岛素强化治疗 2 型糖尿病:经皮胰岛素泵与胰岛素笔餐时胰岛素输注的随机对照研究。
Diabetes Technol Ther. 2019 May;21(5):273-285. doi: 10.1089/dia.2018.0298. Epub 2019 Apr 26.
7
Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.用于 1 型和 2 型成年糖尿病患者群体的持续皮下胰岛素输注(CSII)泵:一项基于证据的分析。
Ont Health Technol Assess Ser. 2009;9(20):1-58. Epub 2009 Oct 1.
8
9
Persistence with Basal-Bolus Insulin Therapy in Patients with Type 2 Diabetes Mellitus and Effect on Clinical and Economic Outcomes: A Retrospective Claims Database Study.2 型糖尿病患者坚持基础-餐时胰岛素治疗对临床和经济结局的影响:一项回顾性理赔数据库研究。
J Manag Care Spec Pharm. 2019 Dec;25(12):1420-1431. doi: 10.18553/jmcp.2019.19097. Epub 2019 Sep 24.
10
Qualitative assessment of user experiences of a novel smart phone application designed to support flexible intensive insulin therapy in type 1 diabetes.对一款旨在支持1型糖尿病灵活强化胰岛素治疗的新型智能手机应用程序用户体验的定性评估。
BMC Med Inform Decis Mak. 2016 Sep 15;16:119. doi: 10.1186/s12911-016-0356-6.

本文引用的文献

1
Abridged for Primary Care Providers.为初级保健提供者缩写。
Clin Diabetes. 2019 Jan;37(1):11-34. doi: 10.2337/cd18-0105.
2
6. Glycemic Targets: .6. 血糖目标: 。
Diabetes Care. 2019 Jan;42(Suppl 1):S61-S70. doi: 10.2337/dc19-S006.
3
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).2018 年美国糖尿病协会(ADA)和欧洲糖尿病研究协会(EASD)共识报告:2 型糖尿病患者高血糖管理。
Diabetes Care. 2018 Dec;41(12):2669-2701. doi: 10.2337/dci18-0033. Epub 2018 Oct 4.
4
American Diabetes Association 78th Scientific Sessions.美国糖尿病协会第 78 届科学会议。
J Diabetes. 2018 Nov;10(11):816-819. doi: 10.1111/1753-0407.12830. Epub 2018 Sep 2.
5
Insulin non-persistence among people with type 2 diabetes: how to get your patients to stay on insulin therapy.2 型糖尿病患者的胰岛素不依从性:如何让您的患者坚持胰岛素治疗。
Postgrad Med. 2018 May;130(4):394-401. doi: 10.1080/00325481.2018.1457396. Epub 2018 Apr 6.
6
American Diabetes Association - 77th Scientific Sessions (June 9-13, 2017 - San Diego, California, USA).美国糖尿病协会——第77届科学会议(2017年6月9日至13日——美国加利福尼亚州圣地亚哥)。
Drugs Today (Barc). 2017 Jul;53(7):405-413. doi: 10.1358/dot.2017.53.7.2669148.
7
Human Insulin for Type 2 Diabetes: An Effective, Less-Expensive Option.用于2型糖尿病的人胰岛素:一种有效且成本较低的选择。
JAMA. 2017 Jul 4;318(1):23-24. doi: 10.1001/jama.2017.6939.
8
Glycemic Control During Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Insulin Injections in Type 2 Diabetes: Individual Patient Data Meta-analysis and Meta-regression of Randomized Controlled Trials.血糖控制在 2 型糖尿病中的连续皮下胰岛素输注与多次皮下胰岛素注射:随机对照试验的个体患者数据荟萃分析和荟萃回归。
Diabetes Care. 2017 May;40(5):715-722. doi: 10.2337/dc16-2201.
9
Benchmarking Insulin Treatment Persistence Among Patients with Type 2 Diabetes Across Different U.S. Payer Segments.在不同美国支付群体中比较 2 型糖尿病患者胰岛素治疗的持续性。
J Manag Care Spec Pharm. 2017 Mar;23(3):278-290. doi: 10.18553/jmcp.2017.16227. Epub 2017 Feb 17.
10
Efficacy of a Tubeless Patch Pump in Patients With Type 2 Diabetes Previously Treated With Multiple Daily Injections.无管贴片泵对既往接受多次每日注射治疗的2型糖尿病患者的疗效
J Diabetes Sci Technol. 2017 Jan;11(1):178-179. doi: 10.1177/1932296816653143. Epub 2016 Jul 9.

2型糖尿病胰岛素给药装置的关键特性:2.0型展位调查

Key Features of Insulin Delivery Devices for Type 2 Diabetes: Type 2.0 Booth Survey.

作者信息

Sze David, Oliveria Teresa

机构信息

Becton Dickinson and Company, Franklin Lakes, NJ.

出版信息

Clin Diabetes. 2020 Jan;38(1):56-61. doi: 10.2337/cd19-0014.

DOI:10.2337/cd19-0014
PMID:31975752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6969661/
Abstract

This article reports on a survey conducted at four diabetes-related annual conferences in 2017 and 2018 to obtain input from the medical community regarding the most important features of insulin delivery devices to address the unmet needs of people with type 2 diabetes who require basal/bolus insulin therapy. The overall patterns of responses compiled from 742 participating health care providers, each voting for three of eight proposed features of insulin delivery devices, were mostly similar numerically at each conference. The features garnering the top three percentages of votes ( = 2,226) averaged for all four conferences were tube-free patch (14.7%), reduced number of insulin injections (14.7%), and dose capture report (14.2%). Four other features received almost as many votes: flexible dosing (14.0%), patient lifestyle app (13.3%), wireless controller (12.7%), and interconnected glucose monitoring (12.6%). This survey provided valuable information that can aid the development of future insulin delivery devices.

摘要

本文报道了2017年和2018年在四次糖尿病相关年度会议上进行的一项调查,旨在从医学界获取关于胰岛素输送装置最重要特征的意见,以满足需要基础/餐时胰岛素治疗的2型糖尿病患者未得到满足的需求。从742名参与调查的医疗保健提供者收集的总体回应模式中,每人对胰岛素输送装置八个提议特征中的三个进行投票,在每次会议上,数字上大多相似。在所有四次会议中获得最高投票百分比(=2226)的三个特征分别是无管贴片(14.7%)、减少胰岛素注射次数(14.7%)和剂量捕获报告(14.2%)。其他四个特征获得的票数几乎相同:灵活给药(14.0%)、患者生活方式应用程序(13.3%)、无线控制器(12.7%)和互联血糖监测(12.6%)。这项调查提供了宝贵的信息,有助于未来胰岛素输送装置的开发。